A cross-sectional study to investigate the association between the Skin condition and Advanced Glycation Endproducts.

A cross-sectional study to investigate the association between the Skin condition and Advanced Glycation Endproducts. - Clinical trial to investigate the association between the Skin condition and Advanced Glycation Endproducts.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052271

Enrollment

Registered

2023-10-01

Start date

2023-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects who are judged as healthy by self-reported health questionnaire. 2. Subjects who agree to participate in this study with a written informed consent after receiving sufficient explanation relating to this study.

Exclusion criteria

Exclusion criteria: 1. Subjects who answered in the self-reported health questionnaire that they currently have a skin disease that requires treatment. 2. Subjects who answered in the self-reported health questionnaire that they have had or are currently suffering from respiratory, gastrointestinal,hepatic/gallbladder/pancreatic, hematologic, renal, endocrine, cardiovascular and/or mental disease that requires hospital treatment. 3. Subjects who had a serious injury or surgical history within 12 weeks prior to this study. 4. Heavy smokers (more than 21 cigarettes per day), alcohol addicts (more than 80g per day alcohol), subjects who are alcohol or drug dependence, subjects who are suspected of alcohol or drug dependence. 5. Subjects who are undergoing special facial care (e.g. facial appliances, aesthetic treatments, peels, laser treatments, etc.) which would affect this study. 6. Subjects who are pregnant or lactating, or subjects who expect to be pregnant during this study. 7. Subjects who have cognitive disorder or who have possibility of the disorder. 8. Subjects who participated and took the study drug in other clinical trials within twelve weeks prior to this study. 9. Subjects who are judges as unsuitable for this study by the principal investigator or subinvestigators.

Design outcomes

Primary

Measure	Time frame
Correlation between Stratum corneum water content and Advanced Glycation Endproducts.	—

Secondary

Measure	Time frame
1. Correlation between transepidermal water loss and AGEs. 2. Correlation between skin viscoelasticity and AGEs. 3. Adverse events.	—

Countries

Japan

Contacts

Public ContactMiho Kuroki

University of Miyazaki Department of Health-Care Research, University of Miyazaki(Kiyotake Branch)

m-kuroki@med.miyazaki-u.ac.jp0985-85-9577

Outcome results